• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

BD Biosciences - Articles and news items

Stem Cells In-depth Focus

Stem Cells: In-depth focus 2014

Genomics, Issue 2 2014, Supplements / 15 April 2014 / Sarah Baird, Graham Kelly, Gil Mor

In this free-to-view in-depth focus: Mesenchymal stem cells in cancer therapy – our chance to take charge, and Ovarian cancer stem cells – an essential target for durable remission…

Stem Cells Supplement 2013

Stem Cells: In-depth focus 2013

Genomics, Issue 2 2013, Supplements / 17 April 2013 / Katharina Drews, James Adjaye, Annette Meeson, George E. Plopper

The promise held by induced pluripotent stem cells for research and regenerative medicine.
Workshop preview – Cell based assays for screening.
Cardiac stem cells.
Stem Cells Roundtable.

Stem Cells Supplement 2012

In-depth focus – Stem Cells

Genomics, Issue 3 2012, Supplements / 5 July 2012 / Michaela E. Sharpe, Mathurin Baquié, Igor Charvet, Luc Stoppini, Karl-Heinz Krause

Stem cell therapies: Assuring safety.
Role of pluripotent stem cells in neurotoxicology testing: Impacts and applied innovations.

High Content Analysis Roundtable

Issue 3 2009, Past issues / 29 May 2009 /

1. How significantly do you feel the Drug Discovery Process has benefited from the application of High Content Analysis techniques?

Anthony Davies: Since the mid 1990’s High-content analysis (HCA) has primarily been used in the later stages of the pre-clinical drug discovery process. However, as HCA techniques have developed and evolved, so has the role of this technology within the discovery process. Today HCA is integrated earlier in drug discovery, for example this technology is now widely utilised in target validation where contextual information obtained from cell based assays allows for better characterisation of biological mechanisms.

 

Webinar: Use of MicroNIR to optimise fluid bed drying and to reduce waste at tablet compressionFIND OUT MORE
+ +